COSMOS 2044 Mission: Overview

The COSMOS 2044 spaceflight was the ninth Soviet-International joint mission dedicated to space biomedicine and the seventh in which the United States has participated. The unmanned Vostok vehicle carried 10 rats and two rhesus monkeys on its 14-day voyage. This spaceflight yielded an unprecedented bounty of data on physiological responses to the microgravity environment. The tissues studied and the numbers and types of studies performed by members of the international science community constituted a new record. Many of the results obtained by the approximately 80 American scientists who participated are reported in the series of COSMOS 2044 papers in this issue. Descriptions of the spaceflight and animal procedures are detailed elsewhere. The broad goals of the space biomedical program are threefold. The first is to characterize qualitatively and quantitatively the biological responses to the microgravity environment, be they adaptive or pathological. The second goal is to clarify the physiological-biochemical mechanisms mediating the responses to microgravity. The third goal of this program is to use the space environment as a tool to better understand adaptive and disease processes in terrestrial organisms.